U.S. health authorities Monday announced plans to undertake a $36 million trial of an AIDS vaccine, the largest such trial to date
Published:
9 July 2002 y., Tuesday
About 16,000 HIV-negative volunteers will participate in the five-year study, to be co-sponsored by the U.S. National Institute of Allergy and Infectious Diseases and the Thai Ministry of Public Health.
Because it will take place in Thailand, the trial has been dubbed the "Thai Vaccine Trial."
Over six months, half of the participants will receive a series of three "primer" shots and two "booster" shots; the other half will receive placebo.
The "prime" part of the vaccine, called ALVAC-HIV, is made by Aventis Pasteur and the "boost," called AIDSVAX-B/E, is made by VaxGen.
Both medications have been studied independently and have generated strong safety records. Dr. Anthony Fauci, chairman of NIAID, expressed optimism.
Šaltinis:
cnn.com
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.
The most popular articles
The world's first full face transplant appears in public, and thanks his doctors.
more »
China's fattest man hospitalized
China's fattest man, weighing 230 kg or 507 pounds, is hospitalised after being diagnosed with heart problems and kidney failure.
more »
A Chinese anti-smoking activist is on a one-man mission to eradicate smoking - one smoker at a time.
more »
A five-month old Siberian tiger with cataracts in both eyes becomes China's youngest animal to undergo surgery.
more »
The Commission has taken further steps against Germany for incorrectly applying EU rules on well established medicinal use when authorising medicinal products pursuant to Directive 2001/83/EC.
more »
Theold Bank today approved a US$$117.70 million IDA credit to India, designed to improve quality of and access to health services in the state of Tamil Nadu.
more »
Livestock at a farm outside of Seoul show symptoms of the highly contagious disease.
more »
A written declaration calling for EU-wide breast cancer screening for women, initiated by MEP Liz Lynne (ALDE, UK) had been signed by sufficient MEPs to qualify as having been endorsed by Parliament, announced the President, thanking those who had signed.
more »
The European Commission has earmarked €21 million for two new research projects on cancer, as part of an international research effort coordinated since 2007 by the International Cancer Genome Consortium (ICGC).
more »
To mark World Health Day, WHO is launching a global campaign to raise awareness of the impact of increasing urbanization on the health and lifestyles of people around the globe.
more »